Literature DB >> 2557114

Tumour necrosis factor.

F R Balkwill.   

Abstract

Tumour necrosis factor, TNF, possesses the attributes of a typical cytokine, being a pleiotropic cell regulatory protein whose activity is largely determined by the cell type to which it binds and the presence of other protein regulators. Thus TNF can be a growth factor, cytotoxin, cytostatic agent or inducer of differentiation. This cytokine is also an important inflammatory mediator regulating the activity of neutrophils, eosinophils, T and B lymphocytes and modulating the properties of the vascular endothelium. All of these actions may play a role in the ability of TNF to induce necrosis of experimental animal tumours, but the potential of this cytokine in therapy of human cancer is uncertain. The increasing evidence for a role for TNF in the pathophysiology of acute and chronic disease makes the use of specific TNF antagonists an equally interesting therapeutic possibility.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557114     DOI: 10.1093/oxfordjournals.bmb.a072330

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  6 in total

Review 1.  Midkine as a regulator of B cell survival in health and disease.

Authors:  Sivan Cohen; Idit Shachar
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

2.  Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.

Authors:  M Z Mazlam; H J Hodgson
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

3.  Decreased luminol-dependent chemiluminescence response of neutrophils to recombinant human tumour necrosis factor in patients with gastric cancer.

Authors:  I A Schepetkin; N V Cherdyntseva; E V Borunov; I L Skutina; S A Naumov
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Injection of recombinant tumor necrosis factor directly into liver metastases: an experimental and clinical approach.

Authors:  J N IJzermans; M Scheringa; G P van der Schelling; R A Geerling; R L Marquet; J Jeekel
Journal:  Clin Exp Metastasis       Date:  1992-03       Impact factor: 5.150

5.  TNF-308 G/A polymorphism and risk of acne vulgaris: a meta-analysis.

Authors:  Jian-Kang Yang; Wen-Juan Wu; Jue Qi; Li He; Ya-Ping Zhang
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

6.  The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice.

Authors:  L Zhao; L-M Ching; P Kestell; B C Baguley
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.